WEST PHARMACEUTICAL SERVICES INC
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.1B | $2.9B | $2.9B | $2.9B | $2.8B |
| Cost of revenue | $2.0B | $1.9B | $1.8B | $1.8B | $1.7B |
| Gross profit | $1.1B | $998.5M | $1.1B | $1.1B | $1.2B |
| Selling, general & administrative | $393.6M | $338.5M | $353.4M | $316.9M | $362.8M |
| Research and development | $74.3M | $69.1M | $68.4M | $58.5M | $52.8M |
| Operating income | $584.9M | $569.9M | $676.0M | $734.0M | $752.3M |
| Interest expense | $500,000 | $3.0M | $9.0M | $7.9M | $8.2M |
| Pretax income | $600.9M | $585.5M | $698.0M | $679.9M | $748.9M |
| Income tax expense | $121.6M | $107.5M | $122.3M | $114.7M | $107.2M |
| Net income | $493.7M | $492.7M | $593.4M | $585.9M | $661.8M |
| Balance Sheet | |||||
| Cash and equivalents | $791.3M | $484.6M | $853.9M | $894.3M | $762.6M |
| Current assets | $2.0B | $1.5B | $1.9B | $1.9B | $1.7B |
| Total assets | $4.3B | $3.6B | $3.8B | $3.6B | $3.3B |
| Current liabilities | $654.9M | $550.4M | $671.8M | $519.0M | $594.1M |
| Total liabilities | $1.1B | $961.1M | $948.5M | $931.9M | $978.4M |
| Total debt | $203.0M | $203.0M | $207.0M | $209.2M | $253.5M |
| Stockholders' equity | $3.2B | $2.7B | $2.9B | $2.7B | $2.3B |
| Cash Flow Statement | |||||
| Cash from operations | $754.8M | $653.4M | $776.5M | $724.0M | $584.0M |
| Depreciation and amortization | $171.4M | $155.4M | $137.3M | $120.6M | $122.3M |
| Stock-based compensation | $23.8M | $18.7M | $23.3M | $23.7M | $37.5M |
| Capital expenditure | $285.9M | $377.0M | $362.0M | $284.6M | $253.4M |
| Free cash flow | $468.9M | $276.4M | $414.5M | $439.4M | $330.6M |
| Dividends paid | $61.2M | $59.1M | $57.0M | $54.1M | $51.1M |
| Share repurchases | $134.0M | $560.9M | $438.3M | $202.8M | $137.1M |
| Impairments | $11.7M | $7.3M | $9.6M | $6.2M | $5.6M |
Shares outstanding 70.6M · Free float 92.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.